Shared on 01 Nov 25
Analysts have maintained their price target for Cooper Companies at $83.00, citing stability in the company’s fundamental metrics and minimal changes in key financial assumptions. What's in the News Jana Partners LLC has urged Cooper Companies to consider strategic alternatives, including a potential merger of its contact lens unit with Bausch + Lomb Corp, and to improve capital allocation and shareholder returns (Key Developments).
Shared on 17 Oct 25
Fair value Decreased 0.23%Global Rollouts And Automation Will Revitalize Contact Lenses
Analysts have slightly lowered their price target for Cooper Companies from $83.19 to $83.00, citing minor adjustments in key financial metrics such as fair value and forward P/E ratio. What's in the News On September 17, 2025, Cooper Companies increased its equity buyback plan by $1,000 million, raising total authorization to $2,000 million (Key Developments).
Shared on 03 Oct 25
Fair value Decreased 1.51%Global Rollouts And Automation Will Revitalize Contact Lenses
Analysts have slightly lowered their price target for Cooper Companies from $84.47 to $83.19. They cite minor adjustments in projected revenue growth and profit margins as the reason for this change.
Shared on 29 Aug 25
Fair value Decreased 9.44%Global Rollouts And Automation Will Revitalize Contact Lenses
The consensus analyst price target for Cooper Companies has been revised downward, primarily reflecting a reduced future P/E multiple while revenue growth expectations remain stable, resulting in a new price target of $84.56. What's in the News Repurchased 724,300 shares for $52.1 million between May and July 2025; total buyback completed is 5,921,842 shares for $836.4 million (3.03% of shares outstanding).
Shared on 07 May 25
Fair value Decreased 13%Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
Shared on 30 Apr 25
Fair value Increased 1.76%Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 16 Apr 25
Fair value Decreased 1.33%Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 0.40%Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 1.04%Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Increased 14%Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
AnalystConsensusTarget made no meaningful changes to valuation assumptions.

